NUP157 Antibody

What is the function of NUP157 in nuclear pore complexes?

NUP157 is a nucleoporin that plays an essential role in the formation and maintenance of nuclear pore complexes (NPCs) in yeast. It functions redundantly with its homolog Nup170p, and together they are critical for the assembly of new NPCs. Research shows that the loss of both NUP157 and NUP170 causes a decrease in NPC density due to defects in new NPC assembly, with preexisting NPCs eventually being lost through dilution as cells grow . This leads to the inhibition of nuclear transport and ultimately cell death. NUP157 appears to be particularly important for a step in NPC assembly that likely coincides with the fusion of outer and inner nuclear membranes and the formation of the nuclear pore .

How can I visualize NUP157 localization in yeast cells?

To visualize NUP157 localization, researchers typically use either GFP-tagged NUP157 constructs for live-cell imaging or indirect immunofluorescence with anti-GFP antibodies when working with GFP-tagged versions. Studies have successfully employed these approaches to observe NUP157 at the nuclear envelope in wild-type cells, as confirmed by co-staining with other nucleoporins . When designing localization experiments, it's advisable to include controls such as known nuclear envelope markers and to compare the distribution pattern with other nucleoporins like Nup49 to confirm proper NPC localization. For optimal visualization, confocal microscopy with appropriate resolution for nuclear pore structures is recommended, as conventional fluorescence microscopy may not provide sufficient resolution to distinguish individual NPCs or clusters.

What are the recommended fixation methods when using NUP157 antibodies for immunofluorescence?

For effective immunofluorescence studies of NUP157 and other nucleoporins, researchers typically employ either paraformaldehyde fixation (3-4%, 15-20 minutes at room temperature) or methanol fixation (-20°C, 5-10 minutes). When examining nuclear envelope structures containing NUP157, a combination approach may be beneficial: initial fixation with paraformaldehyde followed by a brief permeabilization with a low concentration of detergent such as 0.1% Triton X-100. This approach helps preserve nuclear envelope structure while allowing antibody access. In yeast studies, researchers have successfully used indirect immunofluorescence with GFP antibody to detect Nup157 and co-stained with other markers to validate nuclear envelope localization . It's important to optimize the fixation protocol specifically for your cell type, as overfixation can mask epitopes while underfixation may compromise structural integrity.

How can I investigate the dynamics of NUP157 during nuclear pore complex assembly?

To investigate NUP157 dynamics during NPC assembly, a multi-faceted approach is recommended. First, establish an inducible expression system similar to the MET3-promoter system used for NUP170 in previous studies . This allows controlled depletion and re-expression of NUP157 to monitor assembly dynamics. Time-course experiments tracking GFP-tagged NUP157 reincorporation into nuclear pores after induced expression can provide valuable kinetic data. Complement this with transmission electron microscopy (TEM) using potassium permanganate post-fixation to visualize membrane structures and pore formation, allowing quantification of pore density along the nuclear envelope . For higher resolution dynamics, consider photobleaching (FRAP) or photoactivation studies of tagged NUP157 to measure incorporation rates into existing NPCs. Co-immunoprecipitation experiments at different time points during assembly can identify temporal interaction partners. Finally, correlate NUP157 dynamics with nuclear transport efficiency using transport substrates like poly(A) RNA to establish functional consequences of assembly states .

What approaches can be used to study the functional redundancy between NUP157 and NUP170?

To study the functional redundancy between NUP157 and NUP170, several complementary approaches can be employed. First, establish single and double conditional knockout systems using techniques such as the methionine-repressible promoter system (MET3) that has been successfully used for NUP170 in nup157Δ backgrounds . This allows controlled depletion of one or both proteins. Second, conduct quantitative phenotypic analyses including: measuring nuclear pore complex density using transmission electron microscopy (linear counting of pores per μm of nuclear envelope) , assessing nucleocytoplasmic transport efficiency through poly(A) RNA export assays and protein import assays with reporter constructs , and evaluating cell viability after various depletion periods. Third, perform structure-function studies by creating chimeric proteins with swapped domains between NUP157 and NUP170 to identify regions mediating their redundant functions. Fourth, use biochemical approaches to identify shared and unique interaction partners through affinity purification coupled with mass spectrometry. Finally, compare the consequences of depletion on different NPC subcomplex localizations by examining representatives from cytoplasmic filaments, central core, and nucleoplasmic components using fluorescence microscopy .

What methods can be used to investigate potential interactions between NUP157 and other nuclear pore complex components?

To investigate interactions between NUP157 and other NPC components, implement a multi-method approach. Begin with co-immunoprecipitation assays using NUP157 antibodies under native conditions to preserve physiological interactions, followed by mass spectrometry to identify binding partners. Validate key interactions with reciprocal co-IPs and Western blotting. For direct binding studies, use recombinant protein interaction assays with purified NUP157 and candidate partners, such as the in vitro tube binding assay employed for NUP153 studies . Yeast two-hybrid screening can identify novel interactors, though results should be validated due to potential false positives . For in vivo validation, employ proximity-based labeling methods like BioID, where a biotin ligase fused to NUP157 biotinylates proximal proteins. Fluorescence resonance energy transfer (FRET) between tagged proteins can confirm close associations within the NPC. Genetic interaction studies using synthetic lethality or suppressor screens can reveal functional relationships, as demonstrated with UIP4 and NUP157 . Finally, cryo-electron microscopy of isolated NPCs with immunogold labeling can map NUP157's spatial relationships with other nucleoporins at high resolution.

What controls should be included when performing immunoprecipitation with NUP157 antibodies?

When performing immunoprecipitation (IP) with NUP157 antibodies, several essential controls should be incorporated to ensure valid interpretation of results. First, include an isotype control antibody of the same species and class as your NUP157 antibody to identify non-specific binding. Second, perform a pre-clearing step with protein A/G beads alone to reduce background from proteins that interact non-specifically with the beads. Third, include a sample from NUP157-knockout or NUP157-depleted cells as a negative control to verify antibody specificity . Fourth, include RNase and DNase treatments to eliminate nucleic acid-mediated interactions if investigating protein-protein interactions specifically. Fifth, perform reciprocal IPs when possible, using antibodies against putative interaction partners to confirm bidirectional binding. Sixth, include gradient salt washes (150mM to 500mM NaCl) to distinguish between strong and weak interactions. Seventh, validate any newly identified interactions using alternative methods such as proximity ligation assays or FRET. Eighth, when studying interactions with other nucleoporins, compare results under conditions of intact NPCs versus disassembled NPCs (such as during mitosis or with chemical disruptors) to distinguish structural dependencies from direct interactions.

How can I design experiments to study the effects of NUP157 depletion on nuclear pore complex assembly?

To study the effects of NUP157 depletion on NPC assembly, design a comprehensive experimental strategy beginning with creating a conditional expression system. Employ an inducible promoter system (such as the MET3 promoter used for NUP170) to control NUP157 expression in wild-type and nup157Δ backgrounds . Conduct time-course experiments collecting samples at multiple timepoints after NUP157 repression. For each timepoint, implement multiple analytical approaches: quantify NPC density using transmission electron microscopy with potassium permanganate staining to visualize nuclear pores (count pores per μm of nuclear envelope) ; assess nucleocytoplasmic transport functionality through poly(A) RNA export assays (FISH with oligo-dT probes) and protein import assays with reporter constructs ; track the localization of representative nucleoporins from different NPC substructures using fluorescence microscopy to identify potential assembly intermediates that accumulate during depletion ; monitor cell viability and growth rates to correlate NPC loss with physiological consequences; and upon reintroduction of NUP157 expression, assess the kinetics of new NPC formation and incorporation of previously mislocalized nucleoporins. Include parallel experiments with NUP170 depletion alone as a control to distinguish specific effects of NUP157 loss from redundant functions .

What are the best methods for quantifying changes in NUP157 levels and distribution in experimental models?

For quantifying changes in NUP157 levels and distribution, a multi-faceted approach yields the most comprehensive data. For protein level quantification, Western blotting with NUP157-specific antibodies provides relative abundance, while adding recombinant NUP157 standards enables absolute quantification. For higher throughput or sensitivity, consider ELISA or automated capillary western systems (Wes/Jess). For distribution analysis, confocal microscopy with immunofluorescence or GFP-tagged NUP157 visualizes localization patterns, with line-scan intensity profiles across the nuclear envelope providing semi-quantitative distribution data . For precise quantification of NPC density, transmission electron microscopy remains the gold standard, counting pores per μm of nuclear envelope length in cross-sections . To assess assembly defects, track formation of abnormal cytoplasmic foci or nucleoplasmic aggregates containing NUP157 and other nucleoporins using co-localization analysis . For turnover dynamics, implement photobleaching recovery (FRAP) experiments with fluorescently tagged NUP157. When examining disruption phenotypes, establish clear metrics such as percentage of cells showing nuclear mRNA accumulation or frequency of cytosolic spots containing multiple nucleoporins . Finally, correlate changes in NUP157 with functional outcomes using nuclear transport assays to establish physiological significance of the observed alterations.

How can I distinguish between direct and indirect effects when observing phenotypes after NUP157 depletion?

To distinguish between direct and indirect effects of NUP157 depletion, implement a systematic approach beginning with carefully designed time-course experiments. Collect samples at multiple timepoints after NUP157 repression to establish the temporal sequence of events—primary (direct) effects typically manifest earlier than secondary consequences . Compare phenotypes between acute depletion (using rapid degradation systems like auxin-inducible degrons) and chronic depletion to separate immediate functional requirements from adaptive responses. Utilize rescue experiments with structure-function mutants of NUP157 to identify which domains correlate with specific phenotypes. For transport defects, distinguish between general NPC density reduction effects and specific NUP157 functions by normalizing transport rates to NPC numbers determined by electron microscopy . Implement parallel depletion of other nucleoporins (especially the homologous NUP170) to identify shared versus unique phenotypes . Examine whether phenotypes correlate with specific biochemical activities or interaction interfaces of NUP157. Finally, use systems biology approaches like transcriptomics or proteomics at early timepoints after depletion to identify primary response networks before widespread cellular dysfunction occurs.

How should I interpret data showing differences in NUP157 behavior compared to published literature?

When encountering data showing differences in NUP157 behavior compared to published literature, follow a structured analytical approach. First, critically assess methodological differences: examine cell types/strains used (lab strains can develop adaptations), detection methods (antibody epitopes, GFP-tag positions), experimental conditions (temperature, media composition), and quantification approaches . Second, consider biological context variations: cell cycle stage (nucleoporins exhibit cell cycle-dependent behaviors), genetic background differences (particularly in yeast strains), and expression levels of NUP157 and interacting partners . Third, evaluate technical variables: microscopy resolution limits (conventional versus super-resolution), fixation artifacts versus live imaging, and sensitivity thresholds of biochemical assays. Fourth, assess the redundancy factor: different degrees of compensation by NUP170 or other nucleoporins may exist between studies . Fifth, validate your findings with multiple complementary techniques and controls appropriate for each method. Sixth, determine whether differences represent contradictions or extensions of existing knowledge by directly replicating key published experiments alongside your novel approaches. Finally, when publishing, explicitly address discrepancies with previous literature, proposing testable hypotheses to reconcile the differences rather than simply noting their existence.

What emerging technologies show promise for studying NUP157 dynamics and interactions?

Emerging technologies offer unprecedented opportunities for studying NUP157 dynamics and interactions with enhanced precision. Proximity-dependent biotin labeling methods (BioID, TurboID, APEX) can map the NUP157 interaction landscape within intact NPCs by identifying proteins within nanometer-scale proximity. Single-molecule tracking using photoactivatable fluorophores can reveal the recruitment dynamics and residence times of NUP157 at NPCs with millisecond temporal resolution. Cryo-electron tomography combined with subtomogram averaging provides structural insights into NUP157's position within the NPC architecture at sub-nanometer resolution. Lattice light-sheet microscopy enables long-term live imaging of GFP-tagged NUP157 with minimal phototoxicity, revealing assembly dynamics across complete cell cycles. CRISPR-based genomic tagging strategies allow endogenous labeling of NUP157 without overexpression artifacts. High-throughput genetic interaction mapping using CRISPR interference or screening can systematically identify functional relationships between NUP157 and the genome. Integrative structural biology approaches combining cross-linking mass spectrometry, AlphaFold predictions, and experimental validation can model NUP157's molecular interactions. Finally, reconstitution systems using biomimetic nuclear envelopes or DNA origami scaffolds can test minimal requirements for NUP157 function in controlled environments outside the complexity of living cells.

How might research on NUP157 contribute to understanding disease states associated with nuclear pore complex dysfunction?

Research on NUP157 has significant potential to illuminate mechanisms underlying diseases associated with nuclear pore complex dysfunction. Although most studies have focused on yeast NUP157, this research provides foundational understanding of nucleoporin functions that can be translated to human homologs and disease contexts. First, nucleoporin dysfunction has been implicated in neurodegenerative disorders—understanding how NUP157 contributes to NPC assembly and maintenance may reveal mechanisms of age-related NPC deterioration observed in conditions like Alzheimer's disease. Second, viral infections including HIV-1 interact with nucleoporins during nuclear entry—research on nucleoporin-viral interactions, as demonstrated with NUP153 and HIV-1 capsid protein , can be extended to investigate whether NUP157 homologs play similar roles in viral pathogenesis. Third, nucleoporin genes are frequently involved in chromosomal translocations in certain leukemias—studying the normal functions of NUP157 may help understand how nucleoporin fusion proteins contribute to oncogenesis. Fourth, defects in nucleocytoplasmic transport have been identified in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)—NUP157 research could provide insights into how nucleoporin dysfunction affects protein and RNA transport in neurons. Finally, comparative studies between yeast NUP157 and its mammalian homologs can identify evolutionarily conserved mechanisms of NPC assembly and function relevant to human disease states, potentially revealing therapeutic targets for conditions characterized by nuclear pore dysfunction.